Regulatory Open Forum

 View Only
  • 1.  Refuse to Accept

    Posted 31-Jan-2018 13:25
    Hey RAPS!

    So, this document [New Guidance] supersedes the "Refuse to Accept Policy for 510(k)s" issued August 4, 2015. 

    Go ahead and download your copy for review ... and please share your review notes/comments ... we learn best from each other and through our network, so let us know how this new guidance might impact you.

    Thanks.


    ------------------------------
    John Beasley RAC
    Founder and Senior Consultant
    3M
    Henderson NV
    United States
    ------------------------------


  • 2.  RE: Refuse to Accept

    Posted 31-Jan-2018 13:43
    Sorry for my "signature" ... the new RAPS website created a signature and put a former employer ... 3M ... by default.  I will definitely need to review this ... the correct signature is shown here:

    John Beasley, RAC (US)
    Founding Member and Senior Consultant
    MedTech Review, LLC
    www.medtechreview.com
    www.linkedin.com/in/medtechreview





    257 Garnet Garden Street
    Henderson, NV 89015

    USA:  +1 612-889-5168
    SKYPE:   medtechreview






  • 3.  RE: Refuse to Accept

    Posted 01-Feb-2018 07:37
    Lol,  John, I should do this too after changing my old 3M title to "Owner"!

    Hope all is well with you. Perhaps we shall meet up in Vancouver.  

    Ginger Cantor, MBA, RAC
    Founder/Principal Consultant
    Centaur Consulting LLC centaurconsultingllc@gmail.com





  • 4.  RE: Refuse to Accept

    Posted 01-Feb-2018 04:55
    Definitely a good document to read, digest, and follow if you are working on 510(k)s.  In the past, I had used the FDA's own checklist during our technical review (peer review) of 510(k) submission as the last step prior to be submitted which worked really well.  We went from around receiving 70% RTA down to less than 20%.  This was also supported not only following the checklist, but also understanding the needs and expectations of FDA reviewers.  It is a must to follow !  Don't let your company waste time or have to tell your CEO that the 510(k) is delayed because you didn't look at this document !

    ------------------------------
    Richard Vincins RAC
    Vice President Regulatory Affairs
    ------------------------------



  • 5.  RE: Refuse to Accept

    Posted 02-Feb-2018 12:01
    Thank you for the update and notification of this new guidance.  I will read and provide feedback shortly.  I have a somewhat similar question with regards to the checklist and what others are doing.  We have always historically filled out the checklist and submitted it with the applications, however I note that it is "optional".  What do others do and why? Does anyone routinely NOT provide a filled checklist?  Thanks.

    ------------------------------
    Daniel Petersen
    RA Specialist
    Draper UT
    United States
    ------------------------------



  • 6.  RE: Refuse to Accept

    Posted 08-Feb-2018 20:25
    We always provide the completed checklist.

    First we use it internally during peer review to make sure everything is there (and can be found) and then provide it in the submission as we have just created an unambiguous mapping to essential submission content in a format FDA is familiar with. It significantly decreases any confusion between FDA and the Sponsor on what the Sponsor has provided to satisfy each RTA requirement.

    ------------------------------
    Michael Petrini RAC
    Manager, Regulatory Affairs
    Lakewood CO
    United States
    ------------------------------



  • 7.  RE: Refuse to Accept

    Posted 09-Feb-2018 10:55
    I always include it. Usually after the table of contents and before the body of the submission, and I will add the location of the information in the submission - where applicable.


    ------------------------------
    Michael Nilo
    Network Regulatory Partners
    Portland OR
    United States
    ------------------------------



  • 8.  RE: Refuse to Accept

    Posted 12-Feb-2018 01:19
    "Does anyone routinely NOT provide a filled checklist?"

    ​Judging by the high percentage of 510(k)s that FDA refuses to accept, apparently so.  :)

    ------------------------------
    Julie Omohundro, ex-RAC (US, GS), still an MBA
    Principal Consultant
    Class Three, LLC
    Durham, North Carolina, USA
    919-544-3366 (T)
    434-964-1614 (C)
    julie@class3devices.com
    ------------------------------